Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New web tool aims to ease symptoms for young breast cancer survivors

NCT ID NCT04906200

First seen Feb 23, 2026 · Last updated Jun 23, 2026 · Updated 21 times

Summary

This study tests a web-based portal called YES (Young, Empowered & Strong) designed to help adolescent and young adult breast cancer survivors monitor and manage their symptoms. Researchers will compare the quality of life of 400 women who use the portal to those receiving standard care. The goal is to see if the portal can improve well-being and provide helpful resources.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Columbia University Medical Center

    New York, New York, 10032, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, 43210, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

web-based symptom monitoring and self-management portal (YES)

What this could lead to

If it works, this could provide a simple, accessible tool to help young breast cancer survivors better manage their symptoms and improve their quality of life.

What could go wrong

This is a behavioral intervention study, not a drug trial. The benefit may be modest, and results depend on how consistently participants use the portal.

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANATOMIC STAGE 0 BREAST CANCER AJCC V8 ANATOMIC STAGE I BREAST CANCER AJCC V8 ANATOMIC STAGE I BREAST CANCER AJCC V8 ANATOMIC STAGE IA BREAST CANCER AJCC V8 ANATOMIC STAGE IA BREAST CANCER AJCC V8 ANATOMIC STAGE IB BREAST CANCER AJCC V8 ANATOMIC STAGE IB BREAST CANCER AJCC V8 ANATOMIC STAGE II BREAST CANCER AJCC V8 ANATOMIC STAGE II BREAST CANCER AJCC V8 ANATOMIC STAGE IIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIB BREAST CANCER AJCC V8 ANATOMIC STAGE IIB BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIIB BREAST CANCER AJCC V8 ANATOMIC STAGE IIIC BREAST CANCER AJCC V8 PROGNOSTIC STAGE 0 BREAST CANCER AJCC V8 PROGNOSTIC STAGE I BREAST CANCER AJCC V8 PROGNOSTIC STAGE I BREAST CANCER AJCC V8 PROGNOSTIC STAGE IA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IB BREAST CANCER AJCC V8 PROGNOSTIC STAGE II BREAST CANCER AJCC V8 PROGNOSTIC STAGE II BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE III BREAST CANCER AJCC V8 PROGNOSTIC STAGE III BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8